Key points for development of immunotherapy for cancer using T cell defined tumor antigens

Y. Kawakami

研究成果: Article査読

抄録

New immunotherapies using cancer antigens recognized by T-cells have recently been developed and a variety of phase I clinical trals has been conducted in the US and Europe. An anti-tumor effect has already been observed in some protocols. However, many questions still remain to establish effective immunotherapies for cancer. Key points which were raised in the research on immunotherapies against melanoma are discussed in this article.

本文言語English
ページ(範囲)429-433
ページ数5
ジャーナルBiotherapy
13
5
出版ステータスPublished - 1999 6月 26

ASJC Scopus subject areas

  • 腫瘍学
  • 癌研究

フィンガープリント

「Key points for development of immunotherapy for cancer using T cell defined tumor antigens」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル